STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Companies Large-Cap

Eli Lilly Posts Strong Q2 Earnings but GLP-1 Pill Disappointment Weighs on Stock

byLuca Blaumann
August 7, 2025
in Large-Cap, Pharmaceuticals
Reading Time: 2 mins read
Share on TwitterShare on LinkedIn

Zepbound and Mounjaro Drive U.S. Sales, Yet Orforglipron Trial Results Raise Investor Concerns

Eli Lilly (LLY) delivered a solid second-quarter earnings beat, but concerns over its experimental oral GLP-1 pill, orforglipron, overshadowed the strong financials and dragged the stock lower. Despite a 38% year-over-year jump in revenue, shares dipped in early trading Thursday and are down 4% year to date.

The pharmaceutical giant reported Q2 revenue of $15.56 billion, well above Wall Street’s $14.69 billion estimate, with earnings per share of $6.31 versus expectations of $5.56. U.S. sales alone accounted for $10.81 billion, fueled by a 46% increase in sales volume of its GLP-1 blockbusters, Mounjaro and Zepbound. However, an 8% price decline slightly tempered overall growth.

Zepbound, in particular, continues to gain ground in the weight-loss market. According to JPMorgan, Zepbound prescriptions surged 225% year over year to 418,000 weekly prescriptions, surpassing Novo Nordisk’s Wegovy, which grew just 35% with 281,000 weekly prescriptions.

Still, investor enthusiasm cooled over orforglipron, Eli Lilly’s once-promising oral GLP-1 candidate. In late-stage trials, the highest dose saw a 25% patient dropout rate, raising red flags. Mizuho analyst Jared Holz pointed out that even the placebo group had a 29% dropout rate, calling the findings “odd” and prompting calls for more clarity.

The company plans to file orforglipron’s data with the FDA this year, with hopes to launch by 2026. In the meantime, Eli Lilly continues to benefit from Zepbound’s dominance, capturing over 60% of new weight-loss prescriptions in the U.S.

CEO Dave Ricks summed it up: “Lilly delivered another quarter of strong performance,” yet investors remain cautious about the long-term pipeline.

You might like this article:Daxor’s New Handheld Blood Volume Analyzer Gets FDA Green Light

Tags: GrowthLLYMoversNewsStock Market
Previous Post

Daxor’s New Handheld Blood Volume Analyzer Gets FDA Green Light

Next Post

LegalZoom Soars as Bank of America Upgrades Rating on AI Momentum and Subscription Growth

Related Posts

virtual makeup

Ulta Beauty Posts Strong Q2 Results with 9.3% Sales Growth

byLuca Blaumann
August 28, 2025
0

Acquisition of Space NK and Robust Consumer Demand Drive Performance Ulta Beauty (ULTA) delivered a strong second quarter in fiscal...

tesla-2

Tesla’s European Sales Slide Deepens Amid Rising Competition

byLuca Blaumann
August 28, 2025
0

Registrations plunge over 40% in July as rivals gain ground and Musk faces reputational challenges Tesla’s (TSLA) struggles in Europe...

Cracker Barrel Reverts to Classic Logo After Backlash and Trump Pressure

byLiliana Vida
August 27, 2025
0

Shares Jump as Company Abandons Minimalist Redesign Cracker Barrel (CBRL) has scrapped its recent logo redesign after customer backlash and...

Next Post

LegalZoom Soars as Bank of America Upgrades Rating on AI Momentum and Subscription Growth

Latest News

Professional Diversity Network Partners with OOKC Group to Build Web3.0 Banking Platform

Ulta Beauty Posts Strong Q2 Results with 9.3% Sales Growth

Tesla’s European Sales Slide Deepens Amid Rising Competition

Nvidia Surpasses Earnings Expectations as AI Demand Fuels Growth

Cracker Barrel Reverts to Classic Logo After Backlash and Trump Pressure

Based on Your Interest

Large-Cap

U.S. Secures 10% Stake in Intel Amid Tumultuous Turnaround

August 25, 2025
Large-Cap

Casual Dining’s Comeback: Why Sit-Down Chains Are Beating Fast Casual

August 21, 2025
Large-Cap

Intel Seeks More Equity Infusions Amid Mounting Financial Strains

August 20, 2025

Recommended

Mid-Cap

Viking Therapeutics Shares Plunge After High Dropout Rate in Weight-Loss Pill Trial

August 19, 2025
Large-Cap

Intel Shares Surge After $2 Billion SoftBank Investment

August 19, 2025
Bitcoin

Strategy Expands Bitcoin Holdings With $51 Million Purchase

August 18, 2025
Aerospace & Defense

Amphenol Expands Defense Portfolio With $1 Billion Trexon Acquisition

August 18, 2025
Insurance

Buffett Bet Sends UnitedHealth Shares Soaring

August 18, 2025
Stoxpo

Follow us on social media:

Highlights

  • Professional Diversity Network Partners with OOKC Group to Build Web3.0 Banking Platform
  • Ulta Beauty Posts Strong Q2 Results with 9.3% Sales Growth
  • Tesla’s European Sales Slide Deepens Amid Rising Competition
  • Nvidia Surpasses Earnings Expectations as AI Demand Fuels Growth
  • Cracker Barrel Reverts to Classic Logo After Backlash and Trump Pressure

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

Professional Diversity Network Partners with OOKC Group to Build Web3.0 Banking Platform

August 29, 2025
virtual makeup

Ulta Beauty Posts Strong Q2 Results with 9.3% Sales Growth

August 28, 2025
tesla-2

Tesla’s European Sales Slide Deepens Amid Rising Competition

August 28, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?